Skip to main content

Up to date, approved and regulated prescribing and patient information for licensed medicines

Latest medicine updates

Ondansetron 4mg Orodispersible Tablets

Active ingredients/generics: ondansetron

Healthcare Pharma Ltd

Ondansetron 8mg Orodispersible Tablets

Active ingredients/generics: ondansetron

Healthcare Pharma Ltd

Labetalol 5mg/ml solution for injection

Active ingredients/generics: labetalol hydrochloride

Synchrony Pharma Ltd

Dioctyl 100 mg Capsules

Active ingredients/generics: docusate sodium

UCB Pharma Limited

Nytol Original 25mg Tablets

Active ingredients/generics: diphenhydramine hydrochloride

Omega Pharma Ltd

Nytol One-A-Night

Active ingredients/generics: diphenhydramine hydrochloride

Omega Pharma Ltd

Cymevene 500 mg powder for concentrate for solution for Infusion

Active ingredients/generics: ganciclovir sodium

Roche Products Limited

Cymevene 500 mg powder for concentrate for solution for Infusion

Active ingredients/generics: ganciclovir sodium

Roche Products Limited

Naproxen Milpharm 250mg and 500mg tablets

Active ingredients/generics: naproxen

Aurobindo Pharma - Milpharm Ltd.

More medicine updates

Useful links

Drug Safety Update

Latest drug safety advice for prescribers and medicine users, direct from the UK medicines' regulator – the MHRA

Yellow Card

Use the MHRA Yellow Card scheme to report any suspected problems or incidents with healthcare products and devices, as well as reporting side effects to medicines

Search dm+d browser

Find the latest NHS prices, pack sizes and manufacturers on the NHS dictionary of medicines and devices (dm+d)

X-PIL

X-PILs are Patient Information Leaflets (PILs) that have been specifically created for people with sight problems. Where available, they can be found on the Patient Leaflet tab for a medicine.

This site uses cookies. By continuing to browse the site you are agreeing to our policy on the use of cookies. Continue

Find out more here.